23. Wilson Disease: When Should you Think of Wilson Disease?
- E. Jenny Heathcote MB, BS, MD, FRCP, FRCP(C)5,6,7,8
Published Online: 4 SEP 2012
DOI: 10.1002/9781118314968.ch23
Copyright © 2012 John Wiley & Sons, Ltd
Book Title

Hepatology: Diagnosis and Clinical Management
Additional Information
How to Cite
Roberts, E. A. and Hirschfield, G. M. (2012) Wilson Disease: When Should you Think of Wilson Disease?, in Hepatology: Diagnosis and Clinical Management (ed E. J. Heathcote), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781118314968.ch23
Editor Information
- 5
Francis Family Chair in Hepatology Research, Toronto, Ontario, Canada
- 6
University of Toronto, Toronto, Ontario, Canada
- 7
Patient Based Clinical Research Division, Toronto Western Research Institute, Toronto, Ontario, Canada
- 8
University Health Network/Toronto Western Hospital, Toronto, Ontario, Canada
Publication History
- Published Online: 4 SEP 2012
- Published Print: 12 OCT 2012
ISBN Information
Print ISBN: 9780470656174
Online ISBN: 9781118314968
- Summary
- Chapter
- References
Keywords:
- copper;
- hepatolenticular degeneration;
- movement disorder;
- Wilson ATPase;
- ATP7B
Summary
Wilson disease (WD) is a rare autosomal recessive disorder of hepatic copper disposition, which can present as hepatic disease, neurological movement disorders, or psychiatric disease. Though often considered a disease of young adults, WD can present clinically at any age. Diagnosis requires a combination of clinical tests. In a patient with compatible liver disease and/or typical neurologic features, the combination of subnormal serum ceruloplasmin (preferably <140 mg/dL) and elevated basal 24-h urinary copper excretion (>0.6 µmol /24 h or >40 µg /24 h) is highly suggestive of WD. Kayser–Fleischer rings, due to accumulation of copper in the cornea, should be sought by slit-lamp examination, but they may not bepresent in approximately half of all patients. Genetic diagnosis is definitive but not straightforward. WD is eminently treatable. Treatment is life-long. Early diagnosis and treatment provide the best outlook for near-normal life. Discontinuing treatment leads to severe refractory liver dysfunction. First-degree relatives must be investigated for WD once a single family member has been diagnosed with WD. For family screening, genetic testing is most efficient but clinical testing may be more convenient.
